Early Emergence of 5' Terminally Deleted Coxsackievirus-B3 RNA Forms Is Associated with Acute and Persistent Infections in Mouse Target Tissues.
5′ terminal genomic deletion
DBA/2J mouse
enterovirus
persistent
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
28 Jul 2022
28 Jul 2022
Historique:
received:
25
05
2022
revised:
12
07
2022
accepted:
26
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Major EV-B populations characterized by 5′ terminal deletions (5′TD) have been shown to be associated with the development of myocarditis and type 1 diabetes in mice or humans. To date, the dynamics of EV-B 5′TD-RNA forms’ emergence during the course of infection and their impact on cellular functions remain unclear. Using a RACE-PCR approach in CVB3/28-infected mouse organs, we showed an early (3 days post infection, DPI) emergence of major 5′TD populations associated with minor full-length RNA forms. Viral replication activities with infectious particle production were associated with heart, liver, and pancreas acute inflammatory lesions, whereas clearance of viral RNA without organ lesions was observed in the brain, lung, intestines, and muscles from 3 to 7 DPI. At 28 DPI, low viral RNA levels, +/-RNA ratios < 5 associated with viral protein 1 expression revealed a persistent infection in the heart and pancreas. This persistent infection was characterized by molecular detection of only 5′TD RNA forms that were associated with dystrophin cleavage in the heart and insulin production impairment in beta-pancreatic cells. These results demonstrated that major EV-B 5′TD RNA forms can be early selected during systemic infection and that their maintenance may drive EV-induced acute and persistent infections with target cell dysfunctions.
Identifiants
pubmed: 36016091
pii: vaccines10081203
doi: 10.3390/vaccines10081203
pmc: PMC9413645
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fédération française de cardiologie
ID : 2019 dotation
Références
PLoS Genet. 2019 Oct 17;15(10):e1008271
pubmed: 31622336
Microorganisms. 2021 May 22;9(6):
pubmed: 34067388
Sci Rep. 2017 Jul 10;7(1):5013
pubmed: 28694527
J Am Coll Cardiol. 2012 Oct 2;60(14):1295-6
pubmed: 23017536
PLoS Pathog. 2010 May 27;6(5):e1000928
pubmed: 20523896
J Virol. 2017 Jul 27;91(16):
pubmed: 28539455
Diabetologia. 2019 May;62(5):744-753
pubmed: 30675626
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
J Clin Microbiol. 2012 Oct;50(10):3378-80
pubmed: 22837323
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Circulation. 2019 May 14;139(20):2326-2338
pubmed: 30755025
J Virol. 2022 Jan 26;96(2):e0170821
pubmed: 34730395
Nat Med. 1999 Mar;5(3):320-6
pubmed: 10086389
Virology. 2008 Jun 5;375(2):480-91
pubmed: 18378272
Viruses. 2020 Aug 21;12(9):
pubmed: 32839386
PLoS One. 2014 Apr 23;9(4):e95927
pubmed: 24759703
PLoS One. 2015 Dec 11;10(12):e0144606
pubmed: 26659307
J Virol. 1995 Aug;69(8):4607-18
pubmed: 7609025
J Virol. 2005 Mar;79(6):3254-66
pubmed: 15731220
J Med Virol. 2017 Jan;89(1):55-63
pubmed: 27301802
J Biol Chem. 2010 Jul 23;285(30):23208-23
pubmed: 20472559
Virchows Arch. 2017 Dec;471(6):691-705
pubmed: 28889247
J Virol. 2010 May;84(9):4229-42
pubmed: 20164237
J Virol. 2013 Oct;87(19):10423-34
pubmed: 23903828
J Med Virol. 2015 Feb;87(2):240-7
pubmed: 25111164
Discov Med. 2014 Nov;18(100):273-82
pubmed: 25425468
Emerg Infect Dis. 2016 Aug;22(8):1488-90
pubmed: 27434549
J Lab Clin Med. 2003 Sep;142(3):196-204
pubmed: 14532908
Virology. 2010 May 10;400(2):240-7
pubmed: 20189623
Cell. 2021 Jun 24;184(13):3410-3425.e17
pubmed: 34062120
Cell Rep. 2012 Nov 29;2(5):1187-96
pubmed: 23142662
Virus Res. 1995 Feb;35(2):155-67
pubmed: 7762289
Nat Struct Mol Biol. 2010 Feb;17(2):222-9
pubmed: 20062055
J Virol. 2008 Feb;82(4):2033-7
pubmed: 18057248
J Clin Invest. 2013 Dec;123(12):5146-51
pubmed: 24200690
Nat Med. 2002 Aug;8(8):872-7
pubmed: 12118246
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):314-8
pubmed: 1309611
PLoS One. 2017 Oct 3;12(10):e0185819
pubmed: 28973047
Diabetes. 2015 May;64(5):1682-7
pubmed: 25422108
J Virol. 2005 Jun;79(11):7024-41
pubmed: 15890942
Virology. 1995 Feb 20;207(1):68-76
pubmed: 7871753
J Med Virol. 1997 Jun;52(2):206-14
pubmed: 9179770
Exp Cell Res. 1995 Nov;221(1):187-96
pubmed: 7589244
mBio. 2022 Jun 28;13(3):e0085422
pubmed: 35652592
Sci Rep. 2020 Jul 20;10(1):11947
pubmed: 32686697
Sci Rep. 2018 Apr 25;8(1):6510
pubmed: 29695831
Nat Rev Microbiol. 2018 Jun;16(6):368-381
pubmed: 29626210
J Virol. 2000 Feb;74(3):1321-31
pubmed: 10627543
PLoS One. 2015 Sep 25;10(9):e0138546
pubmed: 26405760
Viral Immunol. 2004;17(4):498-515
pubmed: 15671747
Curr Top Microbiol Immunol. 2014;380:129-44
pubmed: 25004816